23 May 2013
Keywords: Sanofi, M&A, Genfar, Eliglustat, Diabetes, Lyxumia, Gaucher's, Bristol-Myers, Plavix, Avapro
Article | 03 October 2012
In what turns out to be a very busy couple of days for French drug major Sanofi (Euronext: SAN), the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
3 October 2012
© 2013 thepharmaletter.com